Profile cover photo
Profile photo
MabVax Therapeutics, Inc.
11 followers -
MabVax Therapeutics (Nasdaq: MBVX) is a biopharmaceutical company focused on the discovery and clinical development of immunotherapies.
MabVax Therapeutics (Nasdaq: MBVX) is a biopharmaceutical company focused on the discovery and clinical development of immunotherapies.

11 followers
About
Posts

Post has attachment
MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones
Add a comment...

Post has attachment
Early detection is critical in treating #ColorectalCancer. Get the facts in our infographic. $MBVX #ColorectalCancerAwarenessMonth
Photo
Add a comment...

Post has attachment
With regular colorectal cancer screening, most polyps can be found and removed before they have the chance to turn into cancer. Learn more in our infographic:
Photo
Add a comment...

Post has attachment
During Colorectal Cancer Awareness Month, learn more about colorectal cancer and how getting screened can save lives:
Photo
Add a comment...

Post has attachment
March is Colorectal Cancer Awareness Month. Learn more about the disease from the Colorectal Cancer Alliance and help spread the word.
Add a comment...

Post has attachment
Did you know? Low physical activity, obesity, smoking and heavy alcohol use are all linked to a higher incidence of Colorectal cancer. More at Fight Colorectal Cancer:
Risks | Fight Colorectal Cancer
Risks | Fight Colorectal Cancer
fightcolorectalcancer.org
Add a comment...

Post has attachment
Our radioimmunotherapy product MVT-1075 combines radiation therapy with tumor specific targeting and is being evaluated in a Phase I clinical study. Learn more here:
Add a comment...

Post has attachment
MabVax will present three posters at the American Assocation of Cancer Research (AACR) Annual Meeting being held April 14-18. The first poster session features MVT-1075 the Company’s novel fully human antibody-based radioimmunotherapy (RIT) currently being evaluated in clinical development for the treatment of pancreatic cancer and other CA19-9 positive malignancies. The second presentation will feature preclinical investigations on the novel fully human antibody targeting the Thomsen-nouveau (Tn) and the sialyl Tn (sTn) cancer antigens. The third poster features the Company’s immunoPET imaging agent MVT-2163 (89Zr-DFO-HuMab5B1), as a companion diagnostic for use in pancreatic cancer and CA19-9 positive malignancies. For more information visit:
Add a comment...

Post has attachment
Colorectal cancer can also be named Colon cancer or Rectal cancer, depending on where the it starts. They are often grouped together because they have many features in common. Learn more about Colorectal cancer at American Cancer Society:
Add a comment...

Post has attachment
A 2017 study published in Journal of National Cancer Institute, which used SEER registry data over 35 years, detected a trend of increasing colorectal cancer rates in young adults ages 20 to 50. Visit US News and World Report to learn more:
Add a comment...
Wait while more posts are being loaded